Other meanings of Astatine-217
Isotopes
Astatine-217 is a radioactive isotope of astatine with 85 protons and 132 neutrons, making it one of the heavier known isotopes of this rare element. It is a short-lived nuclide that undergoes alpha decay, a property that has made it a subject of study in nuclear physics and in the search for superheavy elements.
Astatine-217 was first produced artificially in the mid-20th century, as astatine has no stable isotopes and occurs naturally only in trace amounts as a decay product of heavier elements. It is typically synthesized by bombarding bismuth-209 with alpha particles in a cyclotron, a method that also yields other astatine isotopes. In nuclear reactors, it can appear as a short-lived intermediate in the decay chains of neptunium and plutonium isotopes, though its fleeting existence makes direct observation challenging.
Astatine-217 decays primarily by alpha emission, with a half-life on the order of tens of milliseconds, making it one of the shorter-lived astatine isotopes. Its decay chain leads to bismuth-213, which itself is an alpha emitter used in targeted alpha therapy for cancer treatment. The precise half-life and decay energies have been measured in accelerator experiments, contributing to nuclear data tables used in astrophysical models of the r-process.
Because astatine-217 sits near the predicted island of stability, it has been used as a projectile or target in attempts to synthesize superheavy elements. For instance, fusion reactions involving astatine-217 have been proposed to create elements with atomic numbers around 120, though such experiments remain highly challenging due to the low production rates and short half-life. Studies of its mass and decay properties help refine theoretical models of nuclear shell structure.
Astatine-217 is notable for its role in the neptunium decay series, where it appears as a daughter of francium-221. Its alpha decay leads to bismuth-213, which has found medical applications in alpha-particle radiotherapy, making astatine-217 an indirect precursor in a clinically relevant chain. Additionally, the isotope's short half-life means it has no practical industrial uses, but its study has provided insights into nuclear isomerism and the behavior of neutron-rich nuclei.
Astatine-217 is a transient nuclide with no commercial applications, but its decay chain intersects with medical isotope research.
Help improve the encyclopedia. Reports go straight to the site manager.